The International Financial Reporting Standards (IFRS) Foundation's Capital Markets Advisory Committee (CMAC) has appointed three new members. The new appointees are Deborah Taylor, Jungyeon (Jay) Seo and Xiaolu Wang. CMAC operates independently and provides the International Accounting Standards Board with continuing perspectives from users of financial statements across different markets. Taylor has been working as a professional trainer at Financial Edge for the past seven years. She teaches account ...

Parker-Hannifin Corporation ( PH ) is one of those companies that made its investors very pleased with strong momentum . Now, the company is on the verge of its largest M&A deal in history, paid inThere are many ways sell-side analysts try to find a company’s “fair” value — some useful, others pure illusion. The DCF method is like a massive LEGO set: every tiny assumption has to fit just right, and it opens the door to bias — overconfidence, hindsight, and anchoring. The multiples approach seems easier — co ...

Core Insights - PathoCare Holdings has received a private third-party tender offer for the secondary purchase of shares, indicating an implied company valuation of approximately $1.75 billion [1] - The company previously underwent a $150 million venture investment, recapitalization, and a secondary tender offer at a $500 million valuation [1][5] - An independent financial advisory firm has been appointed to conduct a formal fairness opinion and updated valuation review following the latest tender offer [2] Financial Activities - The earlier $500 million valuation was assigned by Lehrer Financial, a financial consulting firm [2] - PathoCare Holdings has increased the size of its planned private equity financing round from up to $25 million to up to $50 million due to heightened institutional interest and market demand [3] Use of Proceeds - The company plans to utilize the proceeds from the proposed financing to accelerate product development, expand intellectual property, enhance regulatory readiness, and commercialize its flagship diagnostic platform, including the PathoWand point-of-care system [4] Management Commentary - PathoCare Holdings' chairman, Mychal Jefferson, stated that the significant third-party tender offer reflects growing institutional confidence in the long-term potential of the diagnostic platform [4] - The Board is committed to proceeding with discipline and transparency by commissioning an independent fairness opinion before making final decisions [5]

Core Insights - Sportradar Group AG (SRAD) is currently trading at a significant premium due to the market's recognition of its short-term growth prospects and dominant market position [1] Company Overview - The company is acknowledged for its strong growth potential and market leadership, justifying its premium valuation [1] Analyst Background - The analysis is conducted by a finance professional with a Master's in Banking & Finance, specializing in corporate finance, M&A, and investment analysis, particularly in real estate, renewable energy, and equity markets [1]

Alphabet unit Waymo is in talks with potential investors to raise money at a valuation of at least $100 billion, the Information reported on Tuesday, citing people familiar with the ride-hailing servi... ...

Core Insights - Nu Holdings (NU) presents a unique investment opportunity in the financial sector, characterized by a blend of macroeconomic dynamics and company-level valuation [1]. Group 1: Company Overview - Nu Holdings operates in a complex and dynamic market, particularly in Latin America, which allows for in-depth analysis of local assets while considering broader trends [1]. Group 2: Investment Approach - The investment strategy focuses on deep value and long-term perspectives, emphasizing underfollowed names and structural stories within leading companies [1].

Core Insights - Mondelez International, Inc. has successfully passed severe cost inflation onto customers, demonstrating its competitive advantage in the market [1] Valuation Methods - Various methods exist for sell-side analysts to determine a company's fair value, including DCF, multiples approach, and reverse valuation [1] - The DCF method requires precise assumptions, which can introduce bias, while the multiples approach assumes peer companies are fairly priced, a notion often unsupported by historical data [1] - Reverse valuation starts from market price and discount rate, revealing the free cash flow assumptions embedded in the price, providing a direct reality check [1] Free Cash Flow Analysis - A Free Cash Flow to Equity (FCFE) model is utilized to assess what truly belongs to shareholders, calculated as Earnings + Amortization – CAPEX – average acquisition cost = FCFE [1] - The analysis disregards working capital and debt changes, focusing on core business metrics: earnings, amortization, and investments [1] Forecasting Approach - The H-model is applied for forecasts, featuring a 10-year two-stage growth fade with terminal growth equal to the risk-free rate, represented by the 10-year government bond yield [1] - All cash flows are discounted using the cost of equity, calculated as RFR × beta + 5% ERP, resulting in a clear picture of the business's true worth [1]

The rocket-launch company is also reportedly eyeing a public debut. ...

SpaceX is preparing to sell insider shares in a transaction that would value Elon Musk's rocket and satellite maker at a valuation higher than OpenAI's record-setting $500 billion, people familiar with the matter said. Bloomberg's Ed Ludlow reports. ...

Management just traded its wireless spectrum for SpaceX stock, and that's looking like a savvy bet.Shares of satellite cable and wireless company EchoStar (SATS +10.52%) rallied 15.5% on Friday, as of 2:18 p.m. EDT. There was no company-specific news regarding EchoStar's core businesses, which include the upstart Boost Mobile wireless business, a satellite-based broadband business, as well as the declining DISH Network cable business and the over-the-top streaming bundle Sling TV. However, EchoStar's "core" ...